The expression level of GD3 in the malignant T cells was inversely correlated with the production of IL-17A in the benign CD4 T cells, thus implying the involvement of GD3 in regulation of Th17 in the CTCL lesion (Figure 2C). The gene discussed is IL17A; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.